Clinuvel Pharmaceuticals Ltd (CUV.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Sales | 95,018 | 88,178 | 78,321 | 65,722 | 47,976 |
| Cost of Goods | 15,880 | 10,081 | 8,790 | 10,484 | 4,720 |
| Gross Profit | 79,137 | 78,097 | 69,532 | 55,238 | 43,255 |
| Operating Expenses | 33,404 | 30,091 | 25,429 | 19,908 | 15,031 |
| Operating Income | 45,733 | 48,006 | 44,102 | 35,330 | 28,224 |
| Interest Expense | 4,463 | 4,454 | 3,193 | 2,274 | 1,618 |
| Other Income | 10,282 | 7,127 | 4,669 | 1,265 | -893 |
| Pre-tax Income | 51,553 | 50,679 | 45,579 | 34,321 | 25,713 |
| Income Tax | 15,380 | 15,043 | 14,974 | 13,442 | 984 |
| Net Income Continuous | 36,173 | 35,636 | 30,605 | 20,878 | 24,728 |
| Net Income | $36,173 | $35,636 | $30,605 | $20,878 | $24,728 |
| EPS Basic Total Ops | 0.72 | 0.72 | 0.62 | 0.42 | 0.50 |
| EPS Basic Continuous Ops | 0.72 | 0.72 | 0.62 | 0.42 | 0.50 |
| EPS Diluted Total Ops | 0.72 | 0.70 | 0.59 | 0.40 | 0.48 |
| EPS Diluted Continuous Ops | 0.72 | 0.70 | 0.59 | 0.40 | 0.48 |
| EBITDA(a) | $57,197 | $56,276 | $49,561 | $37,353 | $28,193 |